Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer.
from Top News & Analysis https://ift.tt/2NimKIh
0 Response to "Guardant Health soars 70% in first day of trading"
0 Response to "Guardant Health soars 70% in first day of trading"
Post a Comment